Objective — to evaluate the efficiency of local cytokine therapy in early reproductive-aged women with cervititis. Material and methods. The results of investigating the efficiency of local cytokine therapy for cervititis were analyzed in 70 nulliparae of reproductive age 19—25 years with clinical and laboratory signs of this condition. Group 1 included 32 women who received basic anti-inflammatory therapy; Group 2 consisted of 38 women who took the Russian immunotropic drug Superlimf in addition to the basic therapy. Clinical, laboratory, and colposcopic examinations were used. Results. A significant improvement in the rated clinical parameters was noted in both groups. The therapy in Group 2 was found to be more highly effective. Following 3 months, there was a relapse in 31.3±8.2% of the women in Group 1 and 5.3±3.6% in Group 2 (р1—2 <0.01). Conclusion. The immunotropic drug Superlimf contributes to the elimination of impaired local immunoregulatory mechanisms and allows avoidance of recurrent inflammation and a reduction of the risk of epithelial dysplasia in the presence of chronic cervititis. The authors declare no conflicts of interest.